Siemens AG’s $5.1 billion acquisition of Dotmatics enhances its AI capabilities in the life sciences sector. This strategic move focuses on streamlining drug discovery and research processes by integrating Dotmatics’ data science tools, improving efficiency and collaboration across pharmaceutical and biotech domains.
Read More:
- đź”— www.pymnts.com